Skip to content

Clinistique

Active Private limited companyfounded 2017active for 8 yearsHenri Evenepoelstraat 110, 1030 SchaerbeekKBO/BCE: BE 0685.905.509

Board

1 director, no change since 2024
Director (not named in the articles)
appointed by deed of 15-12-2017 term without a fixed end
earlier manager, until 12-04-2024
listed in the 2024 annual accounts, filed on 07-04-2025
Signing authorityThe articles say who may bind the company, for example by signing a contract.
“Chaque gérant - aussi lorsqu'il y en a plusieurs - représente la société vis-à-vis de tiers, ainsi qu'en justice…”
deed of 15-12-2017

Office holders in the KBO →

Mandates through the years

1 name, the dashed line is today

Director (not named in the articles)
BoardEarliermandate already running before its first mention
Mandates as a list
    • Manager (not named in the articles), appointed by deed of 15-12-2017, until 12-04-2024
    • Director (not named in the articles), since before 12-04-2024

Control

Shareholder
This company
Clinistique
Equity -€23,268
Profit €25,147 in 2024

Capital

Contribution
€18,600
Shares
100
Contribution per share
€186
Equity per share
-€233 in 2024
Source
deed of 12-04-2024

Articles of association

deed of 12-04-2024 (in French)
DurationMost companies exist for an unlimited period, until they are dissolved.
Unlimited
Transfer restrictionThis rule says whether shareholders may sell their shares freely or need approval first.
Cession d'actions, tenus de solliciter agrément selon mêmes formalités s'ils ne deviennent pas de plein droit actionnaires
Share issue ruleThe articles set how and by whom new shares are issued.
Apport en numéraire avec émission de nouvelles actions - Droit de préférence, organe d'administration qui procède à l'émission
Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
Fourth Friday of March at 14:00

Shareholders

Stated in the deed deed of 12-04-2024 ↗
  • all shares
At incorporation deed of 15-12-2017 ↗
  • 100 shares (100%)

Capital transactions

Capital over time
  1. 12-04-2024 Converted to unavailable equity · €18,600
  2. 15-12-2017 Incorporation · €18,600 · 100 shares

Next steps